Evidence map›Paper›PMID 35268531›Full record

ArticleJournal of clinical medicine2022

Clinical Characteristics of COVID-19 Patients and Application to an Artificial Intelligence System for Disease Surveillance.

Ying-Chuan Wang, Dung-Jang Tsai, Li-Chen Yen, Ya-Hsin Yao, Tsung-Ta Chiang, Chun-Hsiang Chiu, Te-Yu Lin, Kuo-Ming Yeh, Feng-Yee Chang

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ying-Chuan WangDepartment of Family Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 11499, Taiwan.ORCID 0000-0002-4992-1252
Dung-Jang TsaiGraduate Institute of Life Sciences, National Defense Medical Center, Taipei 11499, Taiwan.ORCID 0000-0002-5531-0810
Li-Chen YenDepartment of Microbiology and Immunology, National Defense Medical Center, Taipei 11499, Taiwan.ORCID 0000-0002-1891-5546
Ya-Hsin YaoNational Defense Medical Center, Taipei 11499, Taiwan.
Tsung-Ta ChiangDivision of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 11499, Taiwan.
Chun-Hsiang ChiuDivision of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 11499, Taiwan.
Te-Yu LinDivision of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 11499, Taiwan.
Kuo-Ming YehDivision of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 11499, Taiwan.
Feng-Yee ChangDivision of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 11499, Taiwan.

Funding

National Science Council, Taipei, Taiwan MOST 109-2327-B-016-004NATIONAL SCIENCE COUNCIL, Taipei, Taiwan MOST 106-2314-B016-024-MY3Tri-Service General Hospital, Taipei, Taiwan 801GB110058Tri-Service General Hospital, Taipei, Taiwan TSGH-C108-135Tri-Service General Hospital, Taipei, Taiwan TSGH-C109-147
6 · The paper itself

Abstract

During the coronavirus disease (COVID-19) pandemic, we admitted suspected or confirmed COVID-19 patients to our isolation wards between 2 March 2020 and 4 May 2020, following a well-designed and efficient assessment protocol. We included 217 patients suspected of COVID-19, of which 27 had confirmed COVID-19. The clinical characteristics of these patients were used to train artificial intelligence (AI) models such as support vector machine (SVM), decision tree, random forest, and artificial neural network for diagnosing COVID-19. When analyzing the performance of the models, SVM showed the highest sensitivity (SVM vs. decision tree vs. random forest vs. artificial neural network: 100% vs. 42.86% vs. 28.57% vs. 71.43%), while decision tree and random forest had the highest specificity (SVM vs. decision tree vs. random forest vs. artificial neural network: 88.37% vs. 100% vs. 100% vs. 94.74%) in the diagnosis of COVID-19. With the aid of AI models, physicians may identify COVID-19 patients earlier, even with few baseline data available, and segregate infected patients earlier to avoid hospital cluster infections and to ensure the safety of medical professionals and ordinary patients in the hospital.

Indexed as

artificial intelligenceartificial neural networkCOVID-19decision treerandom forestsupport vector machine (SVM)

Identifiers

PMID35268531
PMCPMC8911292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.